K221175 is an FDA 510(k) clearance for the Multi-Lancet Device 2, ReliOn Premier Lancing Device, a Multiple Use Blood Lancet For Single Patient Use Only (Class II — Special Controls, product code QRL), submitted by Arkray, Inc. (Kyoto, JP). The FDA issued a Cleared decision on October 17, 2022, 175 days after receiving the submission on April 25, 2022. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4850.
| 510(k) Number | K221175 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2022 |
| Decision Date | October 17, 2022 |
| Days to Decision | 175 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | QRL — Multiple Use Blood Lancet For Single Patient Use Only |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4850 |
| Definition | A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. |